BioPower Operations Corporation Logo

BioPower Operations Corporation

BOPO

(1.8)
Stock Price

0,00 USD

-42480.83% ROA

89.16% ROE

-0.73x PER

Market Cap.

4.221.454,00 USD

-38.17% DER

0% Yield

0% NPM

BioPower Operations Corporation Stock Analysis

BioPower Operations Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

BioPower Operations Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (95.41%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-0.41x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-38%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

6 ROA

The stock's ROA (-43797.29%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

BioPower Operations Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

BioPower Operations Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

BioPower Operations Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

BioPower Operations Corporation Revenue
Year Revenue Growth
2011 0
2012 0 0%
2013 258.734 100%
2014 111.401 -132.25%
2015 13.420 -730.11%
2019 0 0%
2020 0 0%
2021 175.000 100%
2022 571.700 69.39%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

BioPower Operations Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 995.092 100%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

BioPower Operations Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 964.605
2012 984.870 2.06%
2013 1.301.598 24.33%
2014 1.085.226 -19.94%
2015 1.959.596 44.62%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

BioPower Operations Corporation EBITDA
Year EBITDA Growth
2011 -956.953
2012 -974.318 1.78%
2013 -1.296.046 24.82%
2014 -1.085.226 -19.43%
2015 -1.946.176 44.24%
2019 -129.745 -1400%
2020 -129.745 0%
2021 -286.263 54.68%
2022 -595.534 51.93%
2023 -18.780.884 96.83%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

BioPower Operations Corporation Gross Profit
Year Gross Profit Growth
2011 0
2012 0 0%
2013 258.734 100%
2014 111.401 -132.25%
2015 13.420 -730.11%
2019 0 0%
2020 0 0%
2021 175.000 100%
2022 571.700 69.39%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

BioPower Operations Corporation Net Profit
Year Net Profit Growth
2011 -968.655
2012 -1.274.448 23.99%
2013 -1.342.728 5.09%
2014 -2.093.021 35.85%
2015 -2.211.360 5.35%
2019 -129.745 -1604.39%
2020 -129.745 0%
2021 -596.385 78.24%
2022 -1.145.332 47.93%
2023 -19.029.324 93.98%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

BioPower Operations Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

BioPower Operations Corporation Free Cashflow
Year Free Cashflow Growth
2011 -346.476
2012 -242.190 -43.06%
2013 -252.190 3.97%
2014 -337.254 25.22%
2015 -295.487 -14.13%
2019 0 0%
2020 0 0%
2021 -204.027 100%
2022 306.111 166.65%
2023 -380 80655.53%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

BioPower Operations Corporation Operating Cashflow
Year Operating Cashflow Growth
2011 -318.716
2012 -242.190 -31.6%
2013 -236.578 -2.37%
2014 -332.500 28.85%
2015 -286.447 -16.08%
2019 0 0%
2020 0 0%
2021 -204.027 100%
2022 306.111 166.65%
2023 -380 80655.53%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

BioPower Operations Corporation Capital Expenditure
Year Capital Expenditure Growth
2011 27.760
2012 0 0%
2013 15.612 100%
2014 4.754 -228.4%
2015 9.040 47.41%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

BioPower Operations Corporation Equity
Year Equity Growth
2011 -255.798
2012 -1.478.046 82.69%
2013 -1.636.811 9.7%
2014 -2.095.142 21.88%
2015 -3.874.188 45.92%
2019 -4.234.724 8.51%
2020 -4.364.469 2.97%
2021 -5.411.178 19.34%
2022 -5.939.743 8.9%
2023 -6.875.960 13.62%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

BioPower Operations Corporation Assets
Year Assets Growth
2011 294.233
2012 86.309 -240.91%
2013 188.284 54.16%
2014 48.363 -289.31%
2015 31.802 -52.08%
2019 0 0%
2020 0 0%
2021 95.973 100%
2022 14.049 -583.13%
2023 13.224 -6.24%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

BioPower Operations Corporation Liabilities
Year Liabilities Growth
2011 550.031
2012 1.564.355 64.84%
2013 1.825.095 14.29%
2014 2.143.505 14.85%
2015 3.905.990 45.12%
2019 4.234.724 7.76%
2020 4.364.469 2.97%
2021 5.507.151 20.75%
2022 5.953.792 7.5%
2023 6.889.184 13.58%

BioPower Operations Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.12
Price to Earning Ratio
-0.73x
Price To Sales Ratio
0x
POCF Ratio
-57.89
PFCF Ratio
-60
Price to Book Ratio
-0.59
EV to Sales
0
EV Over EBITDA
-1.33
EV to Operating CashFlow
-97.3
EV to FreeCashFlow
-97.3
Earnings Yield
-1.38
FreeCashFlow Yield
-0.02
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.64
Graham NetNet
-0.15

Income Statement Metrics

Net Income per Share
-0.12
Income Quality
0.01
ROE
0.89
Return On Assets
-424.81
Return On Capital Employed
0.75
Net Income per EBT
1.03
EBT Per Ebit
1.06
Ebit per Revenue
0
Effective Tax Rate
0.82

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.25
Return on Tangible Assets
-424.81
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,15
Tangible Book Value per Share
-0.15
Shareholders Equity per Share
-0.15
Interest Debt per Share
0.06
Debt to Equity
-0.38
Debt to Assets
198.47
Net Debt to EBITDA
-0.51
Current Ratio
0
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-0.38
Working Capital
-0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
12893
Debt to Market Cap
0.62

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

BioPower Operations Corporation Dividends
Year Dividends Growth

BioPower Operations Corporation Profile

About BioPower Operations Corporation

BioPower Operations Corporation, through its subsidiaries, focuses on operating HyFi Platform. The HyFi Platform is a proposed decentralized finances (DeFi) exchange marketplace using blockchain platform technology. Its DeFi marketplace offers non-fungible tokens, initial license offerings, bridge loan offerings, pre-special purpose acquisition company, pre-initial public offering funding, CeDeFi commodities exchanges, and membership programs. The company was incorporated in 2010 and is based in Aventura, Florida.

CEO
Mr. Troy MacDonald
Employee
1
Address
20801 Biscayne Boulevard
Aventura, 33180

BioPower Operations Corporation Executives & BODs

BioPower Operations Corporation Executives & BODs
# Name Age
1 Mr. Adam Benchaya
President, Chief Marketing Officer & Director
70
2 Mr. Troy MacDonald
Chief Financial Officer, Chief Executive Officer & Chairman
70
3 Mr. Robert D. Kohn
Co-Founder
70
4 Mr. Paul Christopher Walton
Chief Operating Officer & Director
70
5 Dr. Marco Baez-Velasquez Ph.D.
Chief Science and Technology Officer
70

BioPower Operations Corporation Competitors